Xiaodong Tian

机构：Peking University, Peking University First Hospital · ORCID：0000-0002-0943-5161

发表论文 134 篇 · 总被引 1961 次 · h-index 24

代表论文

• Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition) (2024 · BioScience Trends · 被引 20)
• Hypoxia-induced epigenetic regulation of miR-485-3p promotes stemness and chemoresistance in pancreatic ductal adenocarcinoma via SLC7A11-mediated ferroptosis (2024 · Cell Death Discovery · 被引 17)
• Immunochemotherapeutic nanoparticles inhibit cancer-promoting fibroblasts subtypes for pancreatic ductal adenocarcinoma (2025 · Nano Today · 被引 10)
• Uncovering the inherent link between pseudo-graphite structure and closed-pore formation in hard carbon (2025 · Journal of Colloid and Interface Science · 被引 9)
• Development and external validation of a machine learning-based model to predict postoperative recurrence in patients with duodenal adenocarcinoma: a multicenter, retrospective cohort study (2025 · BMC Medicine · 被引 9)
• Clinicopathologic features and surgery-related outcomes of duodenal adenocarcinoma: A multicenter retrospective study (2024 · Surgery · 被引 8)